Guillermo Ruiz-Irastorza, Diana Paredes-Ruiz, Fernando Arizpe et al. Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough? Lupus Sci Med 2025;12:e001254. doi: ...

The Lupus Foundation of America is a charitable organization with tax-exempt status granted under Section 501(c)(3) of the Internal Revenue Code. The LFA’s Federal ID# is 43-1131436. Donations are tax ...

Background Neuropsychiatric symptoms are highly prevalent among systemic lupus erythematosus (SLE) patients, being clinically observed in up to 80% of adult and 95% of pediatric patients. Type 1 ...

Xinya Tong, Wenwen Chen, Lele Ye, Yanling Xiong, Yuan Xu, Yunhui Luo, Xinhang Xia, Zexia Xu, Yutong Lin, Xinqi Zhu, Nan Wang, Xiangyang Xue, Huidi Zhang, Gangqiang Guo ...

CoronaVac (SARS-CoV-2 inactivated vaccine) has been largely used as the main immunogen for COVID-19 in several countries; however, its immunogenicity, antibody decay and booster dose response in ...

Low versus high initial oral glucocorticoid dose for lupus nephritis: a pooled analysis of randomised controlled clinical trials (6 January, 2025) ...

Background Mycophenolate mofetil (MMF) is commonly used to treat SLE, but many patients experience gastrointestinal (GI) side effects, which are responsible for drug discontinuation in up to 30 ...

How can I track my submitted paper? You can find the status of your manuscript by entering your Manuscript ID on Where Is My Paper? It will also be visible in your Author Dashboard on the manuscript ...

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). 1 Patients with SLE have a 2- to 10-fold higher risk of ischemic heart ...